This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,620.40, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract award does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the specified pharmaceutical product to the government. This contract supports the DLA's mission of providing essential medical supplies and pharmaceuticals to the U.S. military and other federal healthcare programs.
Generated 3/4/25, 11:26 AM